Asset Details
Do you wish to reserve the book?
Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
Do you wish to request the book?
Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
2017
Overview
Background
With the emergence of macrolide resistance, concerns about the efficacy of macrolides for the treatment of
Mycoplasma pneumoniae
(MP) pneumonia in children have been raised. This study aimed to determine the effect of macrolide resistance on the outcome of children who were hospitalized with MP pneumonia.
Methods
Between 2010 and 2015, we performed culture of MP from nasopharyngeal samples obtained from children who were hospitalized with pneumonia at five hospitals in Korea. Macrolide resistance was determined by the analysis of 23S rRNA gene transition and the minimal inhibitory concentrations of four macrolides. Medical records were reviewed to analyze the clinical response to treatment with macrolides.
Results
MP was detected in 116 (4.8%) of the 2436 children with pneumonia. MP pneumonia was prevalent in 2011 and 2015. Of the 116 patients with MP pneumonia, 82 (70.7%) were macrolide-resistant. There were no differences in the age distribution, total duration of fever, and chest x-ray patterns between the macrolide-susceptible and macrolide-resistant groups. After macrolide initiation, mean days to defervescence were longer in the macrolide-resistant group than in macrolide-susceptible group (5.7 days vs. 4.1 days,
P
= 0.021). However, logistic regression analysis revealed that the presence of extrapulmonary signs (
P
= 0.039), homogeneous lobar consolidation (
P
= 0.004), or parapneumonic effusion (
P <
0.001) were associated with fever duration of ≥7 days after the initiation of macrolides, regardless of macrolide resistance.
Conclusions
This study demonstrated that fever duration in MP pneumonia was determined by the radiologic findings of chest x-ray, not by the presence of macrolide resistance. The results highlight the need for future studies to assess therapeutic benefit from macrolides in the treatment of children with MP pneumonia.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Anti-Bacterial Agents - therapeutic use
/ Bacterial and fungal diseases
/ Chest
/ Child
/ Children
/ DNA
/ Effusion
/ Female
/ Fever
/ Humans
/ Infant
/ Macrolides - therapeutic use
/ Male
/ Medicine
/ Mycoplasma pneumoniae - drug effects
/ Nasopharynx - diagnostic imaging
/ Pneumonia, Mycoplasma - diagnostic imaging
/ Pneumonia, Mycoplasma - drug therapy
/ Pneumonia, Mycoplasma - microbiology
/ rRNA
/ rRNA 23S
/ Testing
/ X-Rays
